We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+12.69%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.59%
AUM
$3.05B
AUM Growth
-$542M
Cap. Flow
-$855M
Cap. Flow %
-28%
Top 10 Hldgs %
68.02%
Holding
472
New
104
Increased
41
Reduced
44
Closed
200

Top Buys

1
VRNA
Verona Pharma
VRNA
+$447M
2
CYBR
CyberArk
CYBR
+$424M
3
IPG
Interpublic Group of Companies
IPG
+$96.3M
4
COOP
Mr. Cooper
COOP
+$67.2M
5
AL
Air Lease Corp
AL
+$48.8M

Top Sells

1
WBA
Walgreens Boots Alliance
WBA
+$288M
2
SKX
Skechers
SKX
+$227M
3
BPMC
Blueprint Medicines
BPMC
+$220M
4
CHX
ChampionX
CHX
+$187M
5
ANSS
Ansys
ANSS
+$173M

Sector Composition

1 Technology 23.63%
2 Healthcare 16.98%
3 Communication Services 12.23%
4 Financials 11.14%
5 Consumer Staples 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAT icon
301
Caterpillar
CAT
$404B
– –
-4,200
Closed -$1.63M
CCK icon
302
Crown Holdings
CCK
$13.1B
– –
-87,300
Closed -$8.99M
CDNS icon
303
Cadence Design Systems
CDNS
$101B
– –
-26,400
Closed -$8.14M
CFLT
304
DELISTED
Confluent
CFLT
– –
-300,000
Closed -$7.48M
CGON icon
305
CG Oncology
CGON
$6.13B
– –
-26,000
Closed -$676K
CHX
306
DELISTED
ChampionX
CHX
– –
-7,546,703
Closed -$187M
VISN
307
CALL
Vistance Networks Inc
VISN
$2.72B
– –
-550,000
Closed -$578K
COO icon
308
Cooper Companies
COO
$14.3B
– –
-37,214
Closed -$2.65M
COO icon
309
PUT
Cooper Companies
COO
$14.3B
– –
-20,000
Closed -$8K
COST icon
310
Costco
COST
$419B
– –
-1,000
Closed -$990K
CRNX icon
311
Crinetics Pharmaceuticals
CRNX
$8.88B
– –
-39,978
Closed -$1.15M
CRSP icon
312
CALL
CRISPR Therapeutics
CRSP
$4.78B
– –
-10,000
Closed -$27.3K
CX icon
313
Cemex
CX
$18.9B
– –
-299,870
Closed -$2.08M
CYH icon
314
Community Health Systems
CYH
$476M
– –
-1,500,000
Closed -$5.1M
DASH icon
315
DoorDash
DASH
$81.2B
– –
-5,000
Closed -$1.23M
DAWN
316
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-107,249
Closed -$697K
DKNG icon
317
PUT
DraftKings
DKNG
$12.3B
– –
-15,000
Closed -$4.2K
DLTR icon
318
Dollar Tree
DLTR
$24.7B
– –
-38,000
Closed -$3.76M
DNB
319
DELISTED
Dun & Bradstreet
DNB
– –
-13,678,842
Closed -$124M
DOV icon
320
Dover
DOV
$29.3B
– –
-61,100
Closed -$11.2M
DUK icon
321
Duke Energy
DUK
$98.3B
– –
-144,040
Closed -$17M
DXCM icon
322
DexCom
DXCM
$30.1B
– –
-35,668
Closed -$3.11M
ECVT icon
323
Ecovyst
ECVT
$1.41B
– –
-450,000
Closed -$3.7M
EL icon
324
Estee Lauder
EL
$30B
– –
-40,000
Closed -$3.23M
ESAB icon
325
ESAB
ESAB
$5.7B
– –
-8,900
Closed -$1.07M
11 12
13
14 15

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RCM
RNC Capital Management Los Angeles, California $2.2B AUM 22.93% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

UBS O'Connor's Q3 2025 Portfolio in Review

As of Q3 2025, UBS O'Connor held 472 positions worth $3.05B, down 15% from $3.6B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

UBS O'Connor withdrew a net $855M in Q3 2025, closing 200 positions and reducing 44 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $288M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 15% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, UBS O'Connor opened a new position in Verona Pharma worth $457M.

  • UBS O'Connor's largest Q3 2025 buy was Verona Pharma: 4,283,462 shares worth $457M.
  • UBS O'Connor added most to Interpublic Group of Companies in Q3 2025, an estimated $96.3M increase.
  • UBS O'Connor's biggest Q3 2025 reduction was Kellanova, cutting an estimated $110M.
  • UBS O'Connor fully exited Walgreens Boots Alliance in Q3 2025, selling an estimated $288M.
  • UBS O'Connor's ten largest holdings make up 68% of its $3.05B portfolio in Q3 2025.
  • UBS O'Connor opened 104 new positions and closed 200 in Q3 2025.
  • UBS O'Connor's portfolio value fell 15% quarter-over-quarter to $3.05B.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.